Quarterly report pursuant to Section 13 or 15(d)

Financial Instruments (Level 3 Reconciliation) (Details)

v2.4.0.8
Financial Instruments (Level 3 Reconciliation) (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Assets:  
Fair value of level 3 financial instrument assets $ 11,746
Assumed payments made by Pfizer or assignee (276)
Fair value adjustments to co-promote termination liability (10,334)
Fair value of level 3 financial instrument assets 1,136
Liabilities:  
Fair value of level 3 financial instrument liabilities 21,057
Assumed payments made by Pfizer or assignee (276)
Payments to CVR and other former license holders (1,618)
Fair value adjustments to contingent liabilities (513)
Fair value adjustments to co-promote termination liability (10,334)
Fair value of level 3 financial instrument liabilities $ 8,316